GlassScriptPhysician profile
Edward Green
NPI 1770015638
$10,853.83
in general payments reported to CMS, 2019-2025
71 companies · $3,152 in 2025
The $3,152 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,276 · 2022: $1,266 · 2023: $2,132 · 2024: $3,027 · 2025: $3,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,311.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,040.91 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $796.80 | 2021-2025 | Keytruda, Lynparza, Welireg |
| E.R. Squibb & Sons, L.L.C. | $750.75 | 2021-2025 | Opdivo, Opdualag |
| Astrazeneca Pharmaceuticals LP | $741.19 | 2021-2025 | Enhertu, Imfinzi, Calquence |
| Novartis Pharmaceuticals Corporation | $614.93 | 2022-2025 | Piqray, Kisqali |
| Bayer Healthcare Pharmaceuticals INC. | $588.83 | 2021-2025 | |
| Incyte Corporation | $541.83 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Daiichi Sankyo INC. | $413.58 | 2021-2025 | Enhertu, Datroway |
| Gilead Sciences, INC. | $352.40 | 2021-2025 | Trodelvy |
| Janssen Biotech, INC. | $334.94 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Glaxosmithkline, LLC. | $294.91 | 2023-2025 | Ojjaara, Shingrix |
| Celgene Corporation | $263.76 | 2021-2025 | Pomalyst, Reblozyl, Opdualag |
| Seagen INC. | $259.71 | 2021-2023 | Tukysa, Padcev, Tivdak |
| Array Biopharma INC | $237.68 | 2021-2025 | Mektovi, Braftovi, Lorbrena |
| Beigene USA, INC. | $205.22 | 2021-2025 | Brukinsa |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $184.53 | 2021-2025 | Ultomiris |
| Genentech USA, INC. | $157.66 | 2021-2024 | Polivy, Tecentriq, Alecensa |
| Stemline Therapeutics INC. | $147.12 | 2025 | Orserdu |
| Eisai INC. | $142.91 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $132.50 | 2022-2023 | Imbruvica |
| Genzyme Corporation | $125.01 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $123.35 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.14 | 2023-2025 | Fruzaqla, Ninlaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.94 | 2022-2024 | Gilotrif |
| Tolmar Pharmaceuticals, INC. | $103.72 | 2022 | |
| Sobi, INC | $98.38 | 2022-2025 | |
| Genmab U.S., INC. | $95.05 | 2024 | Epkinly |
| Astellas Pharma US INC | $90.68 | 2021-2025 | Xospata, Padcev |
| Tolmar, INC. | $89.71 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $88.43 | 2021-2025 | Lynozyfic |
| Kite Pharma, INC. | $87.68 | 2023 | Yescarta |
| Mirati Therapeutics, INC. | $87.23 | 2023-2024 | Krazati |
| Geron Corporation | $85.10 | 2025 | Rytelo |
| Legend Biotech USA INC. | $77.72 | 2024-2025 | Carvykti |
| Abbvie INC. | $76.94 | 2022-2025 | |
| Deciphera Pharmaceuticals INC. | $73.90 | 2021-2025 | Qinlock, Tgct |
| Amgen INC. | $72.73 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $70.65 | 2022-2025 | |
| Coloplast Corp | $61.80 | 2022-2023 | Speedicath |
| Axonics, INC. | $55.80 | 2022-2023 | Axonics |
| Pharmacosmos Therapeutics INC. | $50.15 | 2024-2025 | Monoferric |
| Boston Scientific Corporation | $49.69 | 2022 | |
| Kyowa Kirin, INC. | $48.76 | 2023-2024 | Poteligeo |
| Exelixis INC. | $47.91 | 2021-2025 | Cabometyx |
| Epizyme, INC. | $42.49 | 2023-2024 | Tazverik, Onivyde |
| Medtronic, INC. | $40.67 | 2021 | |
| Endo Pharmaceuticals INC. | $40.56 | 2022-2023 | Edex, Xiaflex, Aveed |
| Dendreon Pharmaceuticals LLC | $39.57 | 2022-2025 | Provenge |
| Morphosys, US INC. | $36.54 | 2023-2024 | Monjuvi |
| Sumitomo Pharma America, INC. | $36.18 | 2023-2024 | Gemtesa, Orgovyx |
| Agios Pharmaceuticals, INC. | $34.48 | 2024 | Pyrukynd |
| Urovant Sciences INC | $33.96 | 2022 | |
| Adc Therapeutics America, INC. | $32.27 | 2022-2024 | |
| Tersera Therapeutics LLC | $29.45 | 2023 | Zoladex |
| Antares Pharma, INC. | $28.83 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Iovance Biotherapeutics, INC. | $28.27 | 2025 | Amtagvi |
| Beone Medicines USA, INC. | $27.70 | 2025 | Brukinsa |
| Mission Pharmacal Company | $26.03 | 2023 | Uribel |
| Stryker Corporation | $21.85 | 2025 | Clottriever Bold Catheter |
| Servier Pharmaceuticals LLC | $21.36 | 2023 | |
| Lilly USA, LLC | $20.64 | 2023 | Jaypirca |
| Acrotech Biopharma INC. | $18.03 | 2022 | |
| Clovis Oncology, INC. | $16.32 | 2021 | |
| Recordati_rare_diseases_inc. | $15.91 | 2025 | Sylvant |
| Taiho Oncology, INC. | $15.00 | 2023 | |
| Emd Serono, INC. | $14.65 | 2024 | |
| Puma Biotechnology, INC. | $14.32 | 2021 | |
| Dentsply Ih Ab | $14.12 | 2023 | Lofric |
| Dova Pharmaceuticals | $13.70 | 2021 | |
| Myovant Sciences INC. | $11.26 | 2021 | |
| Heron Therapeutics, INC. | $9.04 | 2021-2022 |
Drugs and devices associated with these payments
Keytruda $689Enhertu $593Nubeqa $456Stivarga $377Vitrakvi $377Jakafi $344Tukysa $311Ojjaara $274Ibrance $269Padcev $267Opdivo $261Kisqali $259Lynparza $233Imfinzi $225Brukinsa $217Inlyta $217Braftovi $192Mektovi $192Opdualag $188Xtandi $183Imbruvica $156Calquence $149Orserdu $147Trodelvy $146Talzenna $145Monjuvi $143Elrexfio $138Darzalex $135Adcetris $130Pomalyst $128Epkinly $127Lorbrena $126Ultomiris $117Tecvayli $106Lenvima $105Yescarta $87.68Krazati $87.23Rytelo $85.10Bosulif $84.53Talvey $82.29Gilotrif $78.85Zepzelca $75.45Welireg $73.24Fruzaqla $66.85Promacta $65.57Piqray $64.60Eligard $63.55Comirnaty $62.66Polivy $60.03Xalkori $59.54Carvykti $53.82Datroway $52.15Pluvicto $51.91Reblozyl $50.79Monoferric $50.15Poteligeo $48.76Tecentriq $46.87Alecensa $46.87Xospata $46.47Scemblix $43.20Tivdak $41.23Doptelet $41.15Speedicath $40.51Fotivda $39.59Vonjo $39.10Ninlaro $37.29Lynozyfic $37.25Cabometyx $34.69Orgovyx $33.84Zoladex $29.45Mekinist $29.19Amtagvi $28.27Jatenzo $26.16Uribel $26.03Cablivi $24.93Ziihera $24.49Tasigna $24.07Tazverik $22.78Clottriever Bold Catheter $21.85Cerdelga $21.53Idhifa $21.36Tibsovo $21.36Shingrix $21.35Gemtesa $21.23Pemazyre $21.17Xiaflex $21.15Aveed $21.15Edex $21.15Fabhalta $20.75Tgct $20.72Qinlock $20.72Jaypirca $20.64Venclexta $19.96Provenge $19.73Onivyde $19.71Pyrukynd $19.30Axonics $18.05Rozlytrek $16.56Gavreto $16.56Premarin $16.27
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.